This article explains how a pharmacovigilance risk management plan supports inspection readiness. It explores EU RMP pharmacovigilance expectations, RMP effectivenes evaluation, additional risk minimisation measures, and common pharmacovigilance inspection findings linked to weak RMP lifecycle management.
